Century-old Vaccine Protects Type 1 Diabetics from Infectious Diseases
BCG-treated individuals had a significantly lower rate of COVID-19 infection compared with the placebo group and a significantly lower rate of infectious diseases overall.
NewsNov | 4 | 2019
A new resource can help you understand options for lifestyle approaches for managing type 2 diabetes. This toolkit was developed for registered dietitian-nutritionists and other clinicians to help adult patients make an informed decision about how to manage type 2 diabetes using a lifestyle approach. The Decision Worksheet is a tool for discussing lifestyle diabetes management options that may or may not focus on weight management, as well as the pros and cons of each option.The decision toolkit was developed by Linda M Delahanty MS, RDN and Suzanne Brodney PhD, RDN clinicians and researchers at Mass General in collaboration with Eileen Stellefson Myers, MPH, RDN
Learn more about the toolkit>>
U.S. News & World Report ranks Mass General Diabetes & Endocrinology among the best in the nation.
BCG-treated individuals had a significantly lower rate of COVID-19 infection compared with the placebo group and a significantly lower rate of infectious diseases overall.
The findings set the stage for novel approaches to modulate insulin resistance in pregnancy and prevent or treat gestational diabetes mellitus (GDM).
The study was designed to compare four major medications approved by the FDA to treat diabetes in combination with metformin, the usual first-line drug.
Researchers have identified numerous genetic clusters that may help explain why people with type 2 diabetes have different clinical presentations.
In this 12-month, placebo-controlled, randomized clinical trial of 26 well-treated persons with HIV without known CVD, eplerenone was associated with a significant reduction in arterial inflammation.
Blocking reductive stress in the liver may benefit people with conditions such as obesity and fatty liver disease.